标题
Oncolytic Virus Immunotherapy for Melanoma
作者
关键词
Adoptive T cell therapy, BRAF inhibitors, Coxsackievirus, Herpesvirus, Immunotherapy, Interleukin-2, Ipilimumab, JX-594, Melanoma, Newcastle disease virus, Oncolytic virus, Programmed death-1 (PD-1), Reovirus, Talimogene laherparepvec, Treatment
出版物
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 16, Issue 3, Pages -
出版商
Springer Nature
发表日期
2015-03-16
DOI
10.1007/s11864-014-0326-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Recent developments in the medical and surgical treatment of melanoma
- (2014) Vita Saranga-Perry et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma
- (2014) David McDermott et al. CANCER TREATMENT REVIEWS
- At the Bedside: Adoptive cell therapy for melanoma-clinical development
- (2014) Jeffrey S. Weber JOURNAL OF LEUKOCYTE BIOLOGY
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma
- (2014) Howard L Kaufman et al. Journal for ImmunoTherapy of Cancer
- Mutations of theBRAFgene in human cancer, by Davieset al. (Nature2002; 417: 949-54)
- (2013) G. W. M. Millington CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Treatment of BRAF-Mutant Melanoma: The Role of Vemurafenib and Other Therapies
- (2013) S Jang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The use of endogenous T cells for adoptive transfer
- (2013) Cassian Yee IMMUNOLOGICAL REVIEWS
- Exploiting the curative potential of adoptive T-cell therapy for cancer
- (2013) Christian S. Hinrichs et al. IMMUNOLOGICAL REVIEWS
- Combination chemotherapy of carboplatin and paclitaxel for metastatic melanoma
- (2013) Yuki Sato et al. JOURNAL OF DERMATOLOGY
- The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
- (2013) Howard L. Kaufman et al. Nature Reviews Clinical Oncology
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
- (2013) Christel Devaud et al. OncoImmunology
- Surgery for Distant Metastatic Melanoma Improves Survival
- (2012) Bin B. R. Kroon ANNALS OF SURGICAL ONCOLOGY
- Surgical Management of Melanoma Lung Metastasis: An Analysis of Survival Outcomes in 292 Consecutive Patients
- (2012) Terence C. Chua et al. ANNALS OF SURGICAL ONCOLOGY
- Systemic Combination Virotherapy for Melanoma with Tumor Antigen-Expressing Vesicular Stomatitis Virus and Adoptive T-cell Transfer
- (2012) D. M. Rommelfanger et al. CANCER RESEARCH
- Fusogenic Oncolytic Herpes Simplex Viruses as a Potent and Personalized Cancer Vaccine
- (2012) Qi-Xiang Li et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Rationale for complete metastasectomy in patients with stage IV metastatic melanoma
- (2012) David W. Ollila et al. JOURNAL OF SURGICAL ONCOLOGY
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Phase II Trial of Intravenous Administration of Reolysin® (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma
- (2012) Evanthia Galanis et al. MOLECULAR THERAPY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer
- (2011) T T Sahin et al. CANCER GENE THERAPY
- Newcastle disease virus: A promising agent for tumour immunotherapy
- (2011) Lixiang Zhao et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma
- (2011) James S. Wilmott et al. CLINICAL CANCER RESEARCH
- A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma
- (2011) Tae-Ho Hwang et al. MOLECULAR THERAPY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer
- (2011) Gery P. Guy et al. PHARMACOECONOMICS
- Epigenetic Silencing of IRF7 and/or IRF5 in Lung Cancer Cells Leads to Increased Sensitivity to Oncolytic Viruses
- (2011) Qunfang Li et al. PLoS One
- Oncogenic Ras Promotes Reovirus Spread by Suppressing IFN-β Production through Negative Regulation ofRIG-ISignaling
- (2010) Maya Shmulevitz et al. CANCER RESEARCH
- OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma
- (2010) Howard L Kaufman et al. Future Oncology
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Completely Regressed Cutaneous Melanocytic Lesion Revisited
- (2009) Timothy W. McCardle et al. SEMINARS IN ONCOLOGY
- Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10
- (2008) Daisuke Watanabe et al. JOURNAL OF DERMATOLOGICAL SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started